4 hours Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Recommendation of “Buy” by Analysts MarketBeat
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock …